Patent details
EP1597251 Title: PYRIMIDINE COMPOUNDS
Basic Information
- Publication number:
- EP1597251
- PCT Application Number:
- PCT/US/2004/004197
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP047102645
- PCT Publication Number:
- WO/2004/074244
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PYRIMIDINE COMPOUNDS
- French Title of Invention:
- COMPOSES DE PYRIMIDINE
- German Title of Invention:
- PYRIMIIDINVERBINDUNGEN
- SPC Number:
Dates
- Filing date:
- 11/02/2004
- Grant date:
- 10/06/2009
- EP Publication Date:
- 10/06/2009
- PCT Publication Date:
- 02/09/2004
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 23/11/2005
- EP B1 Publication Date:
- 10/06/2009
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 11/02/2010
- Expiration date:
- 11/02/2024
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 25/03/2010
- Name:
- GlaxoSmithKline LLC
- Address:
- One Franklin Plaza 200 North 16th Street, Philadelphia, PA 19102, United States (US)
Inventor
1
- Name:
- DAVIS-WARD Ronda, GlaxoSmithKline
- Address:
- United States (US)
2
- Name:
- MOOK Robert Anthony Jr., GlaxoSmithKline
- Address:
- United States (US)
3
- Name:
- NEEB Michael J., GlaxoSmithKline
- Address:
- United States (US)
4
- Name:
- SALOVICH James M., GlaxoSmithKline
- Address:
- United States (US)
Priority
- Priority Number:
- 448795 P
- Priority Date:
- 20/02/2003
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07D 403/12;
| Filing date | Document type | Number of pages |
|---|